Law360, New York (March 25, 2009) -- Boston Scientific has agreed to settle all outstanding litigation with a New Jersey radiologist, putting to rest a three-year-long patent dispute over stent products. In connection with that settlement, the company expects to record a pretax charge to earnings of $50 million in the first quarter of 2009, it said.
(Corrects an article published on March 23.)...
